Breakpoint zone of bcr in chronic myelogenous leukemia does not correlate with disease phase or prognosis

Cancer Genetics and Cytogenetics

Volumn 36, Issue 1, 1988, Pages 117-122

  Przepiorka, Donna ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL LINE; CHROMOSOME BREAKAGE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CYTOLOGY; DNA PROBE; GENE CLUSTER; HEREDITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

BLOTTING, SOUTHERN; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 22; DEOXYRIBONUCLEASE ECORI; DEOXYRIBONUCLEASE HINDIII; GENE REARRANGEMENT; HUMAN; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; NUCLEIC ACID HYBRIDIZATION; PROGNOSIS; RESTRICTION MAPPING; SUPPORT, NON-U.S. GOV'T;

EID: 0024268764     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-4608(88)90081-7     Document Type: Article

References (18)

1. CML patients in blast crisis have breakpoints localized to a specific region of the BCR
2. EM-2 and EM-3: Two new Ph+ myeloid cell lines
3. Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome
4. Separation of HeLa cells by colloidal silica density gradient centrifugation
5. Detection of specific sequences among DNA fragments separated by gel electrophoresis
6. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity
7. Marrow transplantation for the treatment of chronic myelogenous leukemia
8. Nonparametric estimation from incomplete observations
9. A generalized Wilcoxon test for comparing arbitrarily singly-censored samples
10. Identification of moleculaar variants of p210 bcr-abl in chronic myelogenous leukemia
11. bcr-abl RNA in patients with chronic myelogenous leukemia
12. Undetectable bcr-abl rearrangements in some CML patients are due to a deletion mutation in the bcr gene
13. Chronic myelogenous leukemia: Amplification of a rearranged c-abl oncogene in both chronic phase and blast crisis
14. Evidence that the phl gene encodes a 160,000 dalton phosphoprotein with associated kinase activity
15. Analysis of p210 bcr-abl tyrosine kinase activity in various subtypes of Philadelphia chromosome-positive cells from chronic myelogenous leukemia patients
16. Human leukemia K562 cells: Relationship between hemin-mediated erythroid induction, cell proliferation and expression of c-abl and c-myc oncogenes
17. Reduction in protein tyrosine phosphorylation during differentiation of human leukemia cell line K-562